Dosidal · Switzerland

Glatiramyl 40mg/ml, Injektionslösung in einer Fertigspritze

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67526 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67526
atc: L03AX13
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2020-05-12
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L03AX13
authorisation_number: 67526
form: LSPA
holder: Viatris Pharma GmbH
holder_partner_nr: 1100778
it_number: 01.99.0.
name: Glatiramyl 40mg/ml, Injektionslösung in einer Fertigspritze
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
NCDOhxUVTwkfvFJNzhnVFmwIb3lyyZyckCM_1iI4HWmKBQCS_Qf0F-9UcKLfRNm6wjXNOYUYIqA4Sf12x2cg8A
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:67526 · Related records in other markets · Dosidal